• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    Neogenomics Inc. (NEO)

    -NasdaqCM
    6.07 Down 0.04(0.65%) Aug 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.11
    Open:6.10
    Bid:5.25 x 500
    Ask:7.55 x 1000
    1y Target Est:7.30
    Beta:0.39
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:5.98 - 6.33
    52wk Range:3.33 - 6.85
    Volume:318,229
    Avg Vol (3m):451,025
    Market Cap:366.44M
    P/E (ttm):N/A
    EPS (ttm):-0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NEODown 0.65%366.44M
    LHUp 0.05%12.79B
    MYGNDown 0.85%2.35B

    Key Statistics

    Forward P/E (1 yr):60.70
    P/S (ttm):3.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.00
    Quarterly EPS Est (Sep-15) :0.00
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback